| CAS: | 59277-89-3 | ||||||||||||||||||
| 分子式: | C8H11N5O3 | ||||||||||||||||||
| 分子量: | 225.210 | ||||||||||||||||||
| 沸点: | 595ºC at 760 mmHg | ||||||||||||||||||
| 熔点: | 256-257°C | ||||||||||||||||||
| 中文名称: |
| ||||||||||||||||||
| 英文名称: |
| ||||||||||||||||||
| 性质描述: | 白色结晶性粉末。无臭无味,其钠盐溶于水。 | ||||||||||||||||||
| 生产方法: | 将2-氯-9-(-2-羟乙氧基甲基)腺嘌呤与亚硝酸钠作用,得到的2-氯-9-(2-羟乙氧基甲基)次黄嘌呤(熔点>310℃)用液氨饱和,在125℃密闭加热5h即生成无环鸟苷。 | ||||||||||||||||||
| 用途: | 该品是嘌呤核苷衍生物,对DNA的合成有抑制作用,其抗疱疹病毒活性比阿糖腺苷强160倍。临床用于单纯性疱疹病毒脑炎、疱疹病毒角膜炎及外生殖器感染、艾滋病的水痘带状疱疹病毒感染和巨细胞病毒感染,慢性乙型肝炎等。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| A829547 | MACKLIN | 阿昔洛韦 | 97% | 29元/1g; 35元/5g; 59元/25g; 198元/100g; 697元/500g; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||
储存:2~8°C,密封 状态:白色到淡黄色晶体或粉末 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| A797992 | MACKLIN | 阿昔洛韦 | 10mM in DMSO | 356元/1ml; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| A1915 | TCI | Acyclovir | >98.0%(HPLC) | 295元/1G; 460元/5G; 995元/25G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
安全信息
相关法规
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 134052 | J&K | Acyclovir | 99%, 疱疹病毒的胸苷激酶抑制剂 | 275元/1G; 445元/5G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| R11001 | Alfa Aesar | Acyclovir Standard solution | 100ppm | 629元/1ml; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||
安全信息 危险等级 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PHR1254 | Supelco | Acyclovir | Pharmaceutical Secondary Standard; Certified Reference Material | 1162.78元/1 G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 用于质量控制的制药二级标准品,为制药实验室和制造商制备内部工作标准品提供了一种方便且高性价比的替代方案。 应用 阿昔洛韦可用作药物参考标准品,用于通过各种色谱技术测定血浆、血清样品和散装药物/制剂中的分析物。 分析说明 这些二级标准品可追溯至USP、EP(PhEur)和BP一级标准品。 其他说明 本认证参考材料是根据国际标准化组织指南17034和国际标准化组织/国际电工委员会17025生产和认证的。所有关于客户关系管理的信息都可以在分析证书上找到。 附注 想要查看本品的分析证书示例,请在下框中输入LRAC2956。这只是一个示例证书,可能与您收到的批次不符。 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| A0220000 | Aciclovir | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 75 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1012065 | USP | Acyclovir | United States Pharmacopeia (USP) Reference Standard | 4085.07元/300 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Acyclovir is a nucleoside analogue antiviral drug. It is a highly potent inhibitor of herpes simplex virus. It is related to cytarabine, idoxuridine, trifluridine and vidarabine. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0002242 | Aciclovir for impurity C identification | CRS, European Pharmacopoeia (EP) Reference Standard | 1341.2元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 0.3 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0002245 | Aciclovir for system suitability A | CRS, European Pharmacopoeia (EP) Reference Standard | 1341.2元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 20 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0002244 | Aciclovir for impurity G identification | European Pharmacopoeia (EP) Reference Standard | 1341.2元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 0.004 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BP438 | Aciclovir | British Pharmacopoeia (BP) Reference Standard | 1760.91元/100 MG; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| A4669 | Sigma-Aldrich | Acycloguanosine | ≥99% (HPLC), powder | 1714.02元/50 MG; 2846.2元/100 MG; 7876.09元/500 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 无环鸟苷或阿昔洛韦是一种鸟苷类似物。 应用 阿昔洛韦作为I型单纯疱疹病毒抑制剂的应用实例:
包装 50, 100, 500 mg in poly bottle 生化/生理作用 阿昔洛韦是一种抗病毒药,在单纯疱疹病毒胸苷激酶(HSV-TK)的作用下变成三磷酸阿昔洛韦。它竞争性地抑制病毒DNA聚合酶。它对巨细胞病毒和EB(Epstein-Barr)病毒的疗效相对较弱。阿昔洛韦已被用来研究单纯疱疹病毒的潜伏机制。它也具有抗人免疫缺陷型病毒1(HIV-1)活性。 特点和优势 该化合物由GlaxoSmithKline开发。要浏览其他药物开发化合物和批准的药物/候选药物列表,单击此处。 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 076300 | Fluorochem | 2-Amino-9-((2-hydroxyethoxy)methyl)-1H-purin-6(9H)-one | 95% | 242元/5g; 550元/25g; 1210元/100g; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||